🇺🇸 FDA

Company profile · Sponsor

Apogee

Apogee Therapeutics

APGE · NYSE biotech WALTHAM, MA, USA
Pipeline
8
Drugs
0
Patents
7

Quick answer

Apogee (APGE) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 7 patents to this profile..

Company facts

Ticker APGE
Exchange NYSE
Company type biotech
Headquarters WALTHAM, MA, USA
SEC CIK 0001974640

Pipeline (8)

Search pipeline →

  1. ABC294640

    Apogee

    Carcinoma, Hepatocellular

    phase 2 small molecule terminated

    1 trial

  2. ABC294640

    Apogee

    Diffuse Large B Cell Lymphoma

    phase 2 small molecule terminated

    1 trial

  3. APG777

    Apogee

    Atopic Dermatitis

    phase 2 small molecule active

    3 trials

  4. APG777, Placebo

    Apogee

    Atopic Dermatitis

    phase 2 small molecule active

    1 trial

  5. Opaganib

    Apogee

    Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  6. Placebo, APG777

    Apogee

    Atopic Dermatitis

    phase 2 small molecule active

    1 trial

  7. APG777

    Apogee

    Asthma

    phase 1 small molecule active

    1 trial

  8. sphingosine kinase-2 inhibitor ABC294640

    Apogee

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

Patents (7)

Search patents →

  1. US 12410137

    Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12378231

    Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12358979

    Antibodies that bind interleukin 13 and methods of use

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8685936

    Sphingosine kinase inhibitor prodrugs

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8557800

    Sphingosine kinase inhibitors

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8063248

    Sphingosine kinase inhibitors

    Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7338961

    Sphingosine kinase inhibitors

    Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Apogee?

Apogee (APGE) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 7 patents to this profile..

What pipeline programs does Apogee sponsor?

We track 8 ClinicalTrials.gov-linked programs for Apogee, including ABC294640 and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Apogee company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.